197 related articles for article (PubMed ID: 24154489)
21. Comparative study of skin phototoxicity with three drugs by an in vivo mouse model.
Matsumoto N; Akimoto A; Kawashima H; Kim S
J Toxicol Sci; 2010 Feb; 35(1):97-100. PubMed ID: 20118629
[TBL] [Abstract][Full Text] [Related]
22. Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals.
Schümann J; Boudon S; Ulrich P; Loll N; Garcia D; Schaffner R; Streich J; Kittel B; Bauer D
Toxicol Sci; 2014 May; 139(1):245-56. PubMed ID: 24519524
[TBL] [Abstract][Full Text] [Related]
23. Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
Yabe K; Goto K; Jindo T; Sekiguchi M; Furuhama K
Toxicol Lett; 2005 Jul; 157(3):203-10. PubMed ID: 15917145
[TBL] [Abstract][Full Text] [Related]
24. Case series: indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma.
Boudewijns S; Gerritsen WR; Koornstra RH
BMC Cancer; 2014 Dec; 14():967. PubMed ID: 25515496
[TBL] [Abstract][Full Text] [Related]
25. Comparative grepafloxacin phototoxicity in mouse skin.
Owen K
J Antimicrob Chemother; 1998 Aug; 42(2):261-4. PubMed ID: 9738848
[TBL] [Abstract][Full Text] [Related]
26. Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.
Bautista F; Paci A; Minard-Colin V; Dufour C; Grill J; Lacroix L; Varlet P; Valteau-Couanet D; Geoerger B
Pediatr Blood Cancer; 2014 Jun; 61(6):1101-3. PubMed ID: 24375920
[TBL] [Abstract][Full Text] [Related]
27. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
[TBL] [Abstract][Full Text] [Related]
28. Vemurafenib and radiosensitization.
Boussemart L; Boivin C; Claveau J; Tao YG; Tomasic G; Routier E; Mateus C; Deutsch E; Robert C
JAMA Dermatol; 2013 Jul; 149(7):855-7. PubMed ID: 23699661
[TBL] [Abstract][Full Text] [Related]
29. A study of the phototoxic potential of trovafloxacin in BALB/c mice.
Mayne JT; Johnson NJ; Kluwe WM; Lencoski DL; Polzer RJ
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():67-73. PubMed ID: 9222073
[TBL] [Abstract][Full Text] [Related]
30. Skin phototoxicity of cosmetic formulations containing photounstable and photostable UV-filters and vitamin A palmitate.
Gaspar LR; Tharmann J; Maia Campos PM; Liebsch M
Toxicol In Vitro; 2013 Feb; 27(1):418-25. PubMed ID: 22906567
[TBL] [Abstract][Full Text] [Related]
31. FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation.
Kim G; McKee AE; Ning YM; Hazarika M; Theoret M; Johnson JR; Xu QC; Tang S; Sridhara R; Jiang X; He K; Roscoe D; McGuinn WD; Helms WS; Russell AM; Miksinski SP; Zirkelbach JF; Earp J; Liu Q; Ibrahim A; Justice R; Pazdur R
Clin Cancer Res; 2014 Oct; 20(19):4994-5000. PubMed ID: 25096067
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of ultraviolet radiation-induced edema and erythema with topical calmodulin and protein kinase C inhibitors.
Anthony FA; Dowdy JC; Costlow ME
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):227-34. PubMed ID: 7727278
[TBL] [Abstract][Full Text] [Related]
33. Assessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and Pirfenidone phototoxicity in Long-Evans rats.
Adachi T; Satou Y; Satou H; Shibata H; Miwa S; Iwase Y; Yamamoto T; Nishida A; Masutomi N
Int J Toxicol; 2015; 34(1):16-23. PubMed ID: 25432946
[TBL] [Abstract][Full Text] [Related]
34. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin.
He Q; Fang G; Wang Y; Wei Z; Wang D; Zhou S; Fan S; Yuan Z
Photodermatol Photoimmunol Photomed; 2006 Apr; 22(2):100-4. PubMed ID: 16606415
[TBL] [Abstract][Full Text] [Related]
35. Eltrombopag (75 mg) does not induce photosensitivity: results of a clinical pharmacology trial.
Bowen CJ; Lobb KM; Park JW; Sanderson B; Ferguson J
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):243-9. PubMed ID: 20831698
[TBL] [Abstract][Full Text] [Related]
36. The abdominal skin of female Sprague-Dawley rats is more sensitive than the back skin to drug-induced phototoxicity.
Kuga K; Yasuno H; Sakai Y; Harada Y; Shimizu F; Miyamoto Y; Takamatsu Y; Miyamoto M; Sato K
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):46-55. PubMed ID: 28688881
[TBL] [Abstract][Full Text] [Related]
37. DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib.
Peacock M; Brem R; Macpherson P; Karran P
Nucleic Acids Res; 2014 Dec; 42(22):13714-22. PubMed ID: 25414333
[TBL] [Abstract][Full Text] [Related]
38. Vemurafenib. Value unclear in metastatic melanoma.
Prescrire Int; 2012 Dec; 21(133):288-90. PubMed ID: 23373092
[TBL] [Abstract][Full Text] [Related]
39. Assessment of phototoxicity in pigmented Long-Evans rat: sparfloxacin and 8-methoxypsoralen.
Turnock S; Gerbeix C; Thirion-Delalande C; Pearson N; Forster R
Regul Toxicol Pharmacol; 2018 Feb; 92():303-314. PubMed ID: 29196029
[TBL] [Abstract][Full Text] [Related]
40. Clinical Pharmacokinetics of Vemurafenib.
Zhang W; Heinzmann D; Grippo JF
Clin Pharmacokinet; 2017 Sep; 56(9):1033-1043. PubMed ID: 28255850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
